Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019

Background: Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected subnational locations from 1950 to 2019. Methods: 8078 country-years of vital registration and sample registration data, 938 surveys, 349 censuses, and 238 other sources were identified and used to estimate age-specific fertility. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate age-specific fertility rates for 5-year age groups between ages 15 and 49 years. With extensions to age groups 10–14 and 50–54 years, the total fertility rate (TFR) was then aggregated using the estimated age-specific fertility between ages 10 and 54 years. 7417 sources were used for under-5 mortality estimation and 7355 for adult mortality. ST-GPR was used to synthesise data sources after correction for known biases. Adult mortality was measured as the probability of death between ages 15 and 60 years based on vital registration, sample registration, and sibling histories, and was also estimated using ST-GPR. HIV-free life tables were then estimated using estimates of under-5 and adult mortality rates using a relational model life table system created for GBD, which closely tracks observed age-specific mortality rates from complete vital registration when available. Independent estimates of HIV-specific mortality generated by an epidemiological analysis of HIV prevalence surveys and antenatal clinic serosurveillance and other sources were incorporated into the estimates in countries with large epidemics. Annual and single-year age estimates of net migration and population for each country and territory were generated using a Bayesian hierarchical cohort component model that analysed estimated age-specific fertility and mortality rates along with 1250 censuses and 747 population registry years. We classified location-years into seven categories on the basis of the natural rate of increase in population (calculated by subtracting the crude death rate from the crude birth rate) and the net migration rate. We computed healthy life expectancy (HALE) using years lived with disability (YLDs) per capita, life tables, and standard demographic methods. Uncertainty was propagated throughout the demographic estimation process, including fertility, mortality, and population, with 1000 draw-level estimates produced for each metric. Findings: The global TFR decreased from 2•72 (95% uncertainty interval [UI] 2•66–2•79) in 2000 to 2•31 (2•17–2•46) in 2019. Global annual livebirths increased from 134•5 million (131•5–137•8) in 2000 to a peak of 139•6 million (133•0–146•9) in 2016. Global livebirths then declined to 135•3 million (127•2–144•1) in 2019. Of the 204 countries and territories included in this study, in 2019, 102 had a TFR lower than 2•1, which is considered a good approximation of replacement-level fertility. All countries in sub-Saharan Africa had TFRs above replacement level in 2019 and accounted for 27•1% (95% UI 26•4–27•8) of global livebirths. Global life expectancy at birth increased from 67•2 years (95% UI 66•8–67•6) in 2000 to 73•5 years (72•8–74•3) in 2019. The total number of deaths increased from 50•7 million (49•5–51•9) in 2000 to 56•5 million (53•7–59•2) in 2019. Under-5 deaths declined from 9•6 million (9•1–10•3) in 2000 to 5•0 million (4•3–6•0) in 2019. Global population increased by 25•7%, from 6•2 billion (6•0–6•3) in 2000 to 7•7 billion (7•5–8•0) in 2019. In 2019, 34 countries had negative natural rates of increase; in 17 of these, the population declined because immigration was not sufficient to counteract the negative rate of decline. Globally, HALE increased from 58•6 years (56•1–60•8) in 2000 to 63•5 years (60•8–66•1) in 2019. HALE increased in 202 of 204 countries and territories between 2000 and 2019. Interpretation: Over the past 20 years, fertility rates have been dropping steadily and life expectancy has been increasing, with few exceptions. Much of this change follows historical patterns linking social and economic determinants, such as those captured by the GBD Socio-demographic Index, with demographic outcomes. More recently, several countries have experienced a combination of low fertility and stagnating improvement in mortality rates, pushing more populations into the late stages of the demographic transition. Tracking demographic change and the emergence of new patterns will be essential for global health monitoring. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens

Global burden of 87 risk factors in 204 countries and territories, 1990�2019: a systematic analysis for the Global Burden of Disease Study 2019

Background: Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attributable burden of disease. Methods: GBD 2019 estimated attributable mortality, years of life lost (YLLs), years of life lived with disability (YLDs), and disability-adjusted life-years (DALYs) for 87 risk factors and combinations of risk factors, at the global level, regionally, and for 204 countries and territories. GBD uses a hierarchical list of risk factors so that specific risk factors (eg, sodium intake), and related aggregates (eg, diet quality), are both evaluated. This method has six analytical steps. (1) We included 560 risk�outcome pairs that met criteria for convincing or probable evidence on the basis of research studies. 12 risk�outcome pairs included in GBD 2017 no longer met inclusion criteria and 47 risk�outcome pairs for risks already included in GBD 2017 were added based on new evidence. (2) Relative risks were estimated as a function of exposure based on published systematic reviews, 81 systematic reviews done for GBD 2019, and meta-regression. (3) Levels of exposure in each age-sex-location-year included in the study were estimated based on all available data sources using spatiotemporal Gaussian process regression, DisMod-MR 2.1, a Bayesian meta-regression method, or alternative methods. (4) We determined, from published trials or cohort studies, the level of exposure associated with minimum risk, called the theoretical minimum risk exposure level. (5) Attributable deaths, YLLs, YLDs, and DALYs were computed by multiplying population attributable fractions (PAFs) by the relevant outcome quantity for each age-sex-location-year. (6) PAFs and attributable burden for combinations of risk factors were estimated taking into account mediation of different risk factors through other risk factors. Across all six analytical steps, 30 652 distinct data sources were used in the analysis. Uncertainty in each step of the analysis was propagated into the final estimates of attributable burden. Exposure levels for dichotomous, polytomous, and continuous risk factors were summarised with use of the summary exposure value to facilitate comparisons over time, across location, and across risks. Because the entire time series from 1990 to 2019 has been re-estimated with use of consistent data and methods, these results supersede previously published GBD estimates of attributable burden. Findings: The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and economic development, including household air pollution; unsafe water, sanitation, and handwashing; and child growth failure. Global declines also occurred for tobacco smoking and lead exposure. The largest increases in risk exposure were for ambient particulate matter pollution, drug use, high fasting plasma glucose, and high body-mass index. In 2019, the leading Level 2 risk factor globally for attributable deaths was high systolic blood pressure, which accounted for 10·8 million (95 uncertainty interval UI 9·51�12·1) deaths (19·2% 16·9�21·3 of all deaths in 2019), followed by tobacco (smoked, second-hand, and chewing), which accounted for 8·71 million (8·12�9·31) deaths (15·4% 14·6�16·2 of all deaths in 2019). The leading Level 2 risk factor for attributable DALYs globally in 2019 was child and maternal malnutrition, which largely affects health in the youngest age groups and accounted for 295 million (253�350) DALYs (11·6% 10·3�13·1 of all global DALYs that year). The risk factor burden varied considerably in 2019 between age groups and locations. Among children aged 0�9 years, the three leading detailed risk factors for attributable DALYs were all related to malnutrition. Iron deficiency was the leading risk factor for those aged 10�24 years, alcohol use for those aged 25�49 years, and high systolic blood pressure for those aged 50�74 years and 75 years and older. Interpretation: Overall, the record for reducing exposure to harmful risks over the past three decades is poor. Success with reducing smoking and lead exposure through regulatory policy might point the way for a stronger role for public policy on other risks in addition to continued efforts to provide information on risk factor harm to the general public. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens

Ácidos graxos da gema e composição do ovo de poedeiras alimentadas com rações com farelo de coco Yolk fatty acids and egg components from layers fed diets with coconut meal

O objetivo deste trabalho foi avaliar o efeito da inclusão do farelo de coco (FC) na ração e do tempo de alimentação de poedeiras comerciais, sobre os ácidos graxos da gema e os componentes do ovo. O delineamento foi em esquema fatorial 5x2, com cinco níveis de inclusão do FC (0, 5, 10, 15 e 20%) e dois tempos de alimentação (14 e 28 dias). Foram avaliados o peso e as porcentagens de albúmen, gema e casca dos ovos, bem como os sólidos e lipídios totais e o perfil de ácidos graxos das gemas. A inclusão do FC e o tempo de alimentação influenciaram apenas a proporção de ácido mirístico na gema, que aumentou com a inclusão do FC aos 28 dias de alimentação. Os ácidos esteárico e oléico variaram somente com o tempo de alimentação, e as maiores concentrações foram obtidas aos 28 dias. A relação de ácidos graxos poliinsaturados para ácidos graxos saturados da gema diminuiu a partir de 10% de inclusão e aumentou com o tempo de alimentação das aves. O uso de farelo de coco, na ração de poedeiras comerciais, não influencia a proporção dos componentes do ovo, apenas altera a concentração do ácido mirístico da gema.<br>The objective of this work was to evaluate the effects of coconut meal (CM) inclusion in commercial layer diets and feeding time, on egg components and yolk fatty acid composition. The experiment followed a factorial design 5x2, with five levels of CM inclusion (0, 5, 10, 15 and 20%) and two feeding time (14 and 28 days). Parameters evaluated included: egg weight, and albumen, yolk and shell percentages, as well as solids, lipids and fatty acid profile of the yolk. The inclusion of CM and feeding time affected the yolk content of myristic acid which increased with CM level and with feeding time. The levels of stearic and oleic acids in the yolk varied with feeding time and were higher in the eggs after 28 days. Polyunsaturated to saturated fatty acid ratio in yolk decreased, when dietary CM levels were higher than 10%, and increased with longer feeding time. The use of CM in laying hen diets does not influence egg composition but increases myristic acid content of the yolk

The Study Of Cardiovascular Risk In Adolescents - Erica: Rationale, Design And Sample Characteristics Of A National Survey Examining Cardiovascular Risk Factor Profile In Brazilian Adolescents

Background: The Study of Cardiovascular Risk in Adolescents (Portuguese acronym, "ERICA") is a multicenter, school-based country-wide cross-sectional study funded by the Brazilian Ministry of Health, which aims at estimating the prevalence of cardiovascular risk factors, including those included in the definition of the metabolic syndrome, in a random sample of adolescents aged 12 to 17 years in Brazilian cities with more than 100,000 inhabitants. Approximately 85,000 students were assessed in public and private schools. Brazil is a continental country with a heterogeneous population of 190 million living in its five main geographic regions (North, Northeast, Midwest, South and Southeast). ERICA is a pioneering study that will assess the prevalence rates of cardiovascular risk factors in Brazilian adolescents using a sample with national and regional representativeness. This paper describes the rationale, design and procedures of ERICA. Methods/Design: Participants answered a self-administered questionnaire using an electronic device, in order to obtain information on demographic and lifestyle characteristics, including physical activity, smoking, alcohol intake, sleeping hours, common mental disorders and reproductive and oral health. Dietary intake was assessed using a 24-hour dietary recall. Anthropometric measures (weight, height and waist circumference) and blood pressure were also be measured. Blood was collected from a subsample of approximately 44,000 adolescents for measurements of fasting glucose, total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, glycated hemoglobin and fasting insulin. Discussion: The study findings will be instrumental to the development of public policies aiming at the prevention of obesity, atherosclerotic diseases and diabetes in an adolescent population.151Schmidt, M.I., Duncan, B.B., Silva, G.A., Menezes, A.M., Monteiro, C.A., Barreto, S.M., Chronic non-communicable diseases in brazil: Burden and current challenges (2011) Lancet, 377 (9781), pp. 1949-1961Juonala, M., Viikari, J.S., Kahonen, M., Taittonen, L., Laitinen, T., Hutri-Kahonen, N., Life-time risk factors and progression of carotid atherosclerosis in young adults: The cardiovascular risk in young finns study (2010) Eur Heart J., 31 (14), pp. 1745-1751WHO, Obesity - Preventing and managing the global epidemic (2004) Geneva: Report of a WHO Consultation on Obesity, , World Health OrganizationJuonala, M., Magnussen, C.G., Berenson, G.S., Venn, A., Burns, T.L., Sabin, M.A., Childhood adiposity, adult adiposity, and cardiovascular risk factors (2011) N Engl J Med., 365 (20), pp. 1876-1885Williams, D.E., Cadwell, B.L., Cheng, Y.J., Cowie, C.C., Gregg, E.W., Geiss, L.S., Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in us adolescents, 1999-2000 (2005) Pediatrics, 116 (5), pp. 1122-1126IBGE, (2010) Antropometria E Estado Nutricional de Crianças, Adolescentes E Adultos No Brasil2008-2009, p. 130. , Pesquisa de Orçamentos Familiares (POF). Rio de Janeiro: Instituto Brasileiro de Geografia e EstatísticaFreedman, D.S., Khan, L.K., Dietz, W.H., Srinivasan, S.R., Berenson, G.S., Relationship of childhood obesity to coronary heart disease risk factors in adulthood: The bogalusa heart study (2001) Pediatrics, 108 (3), pp. 712-718Franks, P.W., Hanson, R.L., Knowler, W.C., Sievers, M.L., Bennett, P.H., Looker, H.C., Childhood obesity, other cardiovascular risk factors, and premature death (2010) N Engl J Med., 362 (6), pp. 485-493Juonala, M., Viikari, J.S., Raitakari, O.T., Main findings from the prospective cardiovascular risk in young finns study (2013) Curr Opin Lipidol, 24 (1), pp. 57-64Vasconcellos, M.T.L., Silva, P.L.N., Szklo, M., Bloch, K.V., Kuschnir, M.C.C., Klein, C.H., Desenho da amostra do estudo de riscos cardiovasculares em adolescentes (ERICA) (2015) Cadernos de Saúde Pública, , In pressCenso Escolar - Inep, , http://portal.inep.gov.br/basica-censoCastro, I.R., Cardoso, L.O., Engstrom, E.M., Levy, R.B., Monteiro, C.A., Surveillance of risk factors for non-communicable diseases among adolescents: The experience in rio de janeiro, Brazil (2008) Cad Saude Publica, 24 (10), pp. 2279-2288Farias, J.C., Jr., Lopes, A.S., Mota, J., Santos, M.P., Ribeiro, J.C., Hallal, P.C., Validade e reprodutibilidade de um questionário para medida de atividade física em adolescentes: Uma adaptação do self-administered physical activity checklist (2012) Rev Bras Epidemiol., 15 (1), pp. 198-210Biddle, S., Sallis, J.F., Cavill, N.A., Young and active? Young people and health enhancing physical activity (1998) Evidence and Implication, , London: Health Education AuthorityMari, J.J., Williams, P., A comparison of the validity of two psychiatric screening questionnaires (GHQ-12) (1985) Psychol Med., 15 (3), pp. 651-659Conway, J.M., Ingwersen, L.A., Vinyard, B.T., Moshfegh, A.J., Effectiveness of the us department of agriculture 5-step multiple-pass method in assessing food intake in obese and nonobese women (2003) Am J Clin Nutr., 77 (5), pp. 1171-1178(2011) 2008-2009. Tabela de Medidas Referidas Para Os Alimentos Consumidos No Brasil, , Pesquisa de Orçamentos Familiares (POF), Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística(2011) 2008-2009 Tabela de Composição Nutricional Dos Alimentos Consumidos No Brasil, , Pesquisa de Orçamentos Familiares (POF), Rio de Janeiro: Instituto Brasileiro de Geografia e EstatísticaMultiple Source Method (MSM), , https://msm.dife.de/Lohman, T.G., Roche, A.F., Martorell, R., (1988) Anthropometric Standardization Reference Manual: Human Kinetics BooksDe Onis, M., Onyango, A.W., Borghi, E., Siyam, A., Nishida, C., Siekmann, J., Development of a who growth reference for school-aged children and adolescents (2007) Bull World Health Organ, 85 (9), pp. 660-667Obesity: Preventing and managing the global epidemic (2000) Report of a WHO Consultation, 894, pp. i-xi. , World Health Organ Tech Rep Ser., 1-253The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents (2004) Pediatrics, 114 (2), pp. 555-576. , National High Blood Pressure Education Program Working Group on High Blood Pressure in ChildrenStergiou, G.S., Yiannes, N.G., Rarra, V.C., Validation of the omron 705 IT oscillometric device for home blood pressure measurement in children and adolescents: The arsakion school study (2006) Blood Press Monit., 11 (4), pp. 229-234Pickering, T.G., Hall, J.E., Appel, L.J., Falkner, B.E., Graves, J., Hill, M.N., Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: A statement for professionals from the subcommittee of professional and public education of the American heart association council on high blood pressure research (2005) Circulation, 111 (5), pp. 697-716Xavier, H.T., Izar, M.C., Faria Neto, J.R., Assad, M.H., Rocha, V.Z., Sposito, A.C., V brazilian guidelines on dyslipidemias and prevention of atherosclerosis (2013) Arq Bras Cardiol., 101 (4), pp. 1-20Diagnosis and classification of diabetes mellitus (2010) Diabetes Care, 33, pp. S62-S69Back Giuliano Ide, C., Caramelli, B., Pellanda, L., Duncan, B., Mattos, S., Fonseca, F.H., I guidelines of prevention of atherosclerosis in childhood and adolescence (2005) Arq Bras Cardiol, 85, pp. 4-36Medicina Laboratorial, , http://www.sbpc.org.br/?C=133Programa Nacional de Controle de Qualidade, , http://www.pncq.org.br/, American Diabetes AssociationHabicht, J.P., Standardization of quantitative epidemiological methods in the field (1974) Bol Oficina Sanit Panam, 76 (5), pp. 375-38